Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy
肿瘤衍生的 IL33 促进组织驻留 CD8+ T 细胞,并且是检查点阻断肿瘤免疫治疗所必需的
期刊:Cancer Immunology Research
影响因子:8.1
doi:10.1158/2326-6066.CIR-19-1024
Lujun Chen, Runzi Sun, Junchi Xu, Wensi Zhai, Dachuan Zhang, Min Yang, Cuihua Yue, Yichao Chen, Song Li, Heth Turnquist, Jingting Jiang, Binfeng Lu
信号转导
肿瘤
T细胞
Functional/Block/Neutralize
WB
Checkpoint
Mouse
PDCD1